The U.S. Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies ...
Federal health officials said testosterone therapy warning labels could be updated after a review found current evidence did ...
The Trump administration wants to update warning labels on testosterone replacement therapies, saying newer evidence does not ...
The notion of women “having it all” entered the public consciousness in the 1980s, thanks to a self-help book of the same name by longtime Cosmopolitan editor Helen Gurley Brown. Ever since, the ...
Fertility may not be a reason for men to avoid GLP-1 medications. In fact, they could see an improvement.After 24 weeks of treatment with GLP-1s, a class of medications ...
The 2015 warnings were added because concerns about heart risks were raised, plus evidence of benefits were “limited” at the ...
HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical ...
FDA is removing warning labels from testosterone replacement therapy, or TRT, as a key advancement of men's health.
But on June 18, the U.S. Department of Health and Human Services (HHS) announced that it is requesting updates to ...
The U.S. Department of Health and Human Services wants to remove some of the stigma from testosterone treatment.
The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after ...
Two recent studies suggest that treating obesity and metabolic dysfunction with GLP-1 drugs could help restore hormonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results